UNSPSC 85491936: Replacement of left pulmonary artery with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of left pulmonary artery with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02RR4KZ

UNSPSC 85491936 Replacement of left pulmonary artery with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows no relevant recent state and local procurement activity. The code describes a highly specialized surgical procedure for pulmonary artery replacement; the six recent opportunities posted by state and local jurisdictions between July and September 2026 address independent medical evaluations for pension disability determinations, surgical benefit carve-outs for employee health plans, occupational medical surveillance, emergency and specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing. None of these solicitations involve pulmonary artery replacement procedures or the interventional cardiology and cardiothoracic surgery services that the code nominally describes. State and local governments do not typically procure individual surgical procedures through RFP or ITB mechanisms; they contract with hospital systems, physician networks, or managed care organizations that deliver a broad portfolio of acute and specialty care.

The mismatch between the code's nominal scope and actual recent activity suggests the code assignment reflects a classification error in one or more jurisdictions' procurement systems rather than genuine state and local demand for this specific procedure. Vendors pursuing state and local healthcare opportunities should focus instead on broader service categories such as managed care administration, employee health benefits programs, occupational health surveillance, and temporary clinical staffing — where the recent activity and geographic spread (Arizona, California, Florida, and Washington between August and October 2026) clearly demonstrate active market engagement.